This site explains current ME/CFS research in topic-based summaries. Each thread focuses on one research area, such as a possible treatment, a disease mechanism, a diagnostic tool, or a care question. The goal is to help readers quickly see what researchers are studying, what the evidence currently suggests, what is still uncertain, and where to read next.
The thread groups separate treatment directions from disease mechanisms and from diagnostic, symptom, and care-context research. Treatments & Interventions tracks candidate therapies, devices, and clinical intervention evidence; Disease Models & Mechanisms tracks biological explanations and pathway-level research; Diagnostics, Symptoms & Care Context tracks measurement, patient characterization, symptom physiology, and clinical-support evidence.
Threads by Last Update
- Jun 28, 2026 - Clinical Characterization & Epidemiology (Diagnostics, Symptoms & Care Context)
- Jun 28, 2026 - Emerging Pharmacotherapy (Treatments & Interventions)
- Jun 28, 2026 - Immune Dysregulation & Chronic Inflammation (Disease Models & Mechanisms)
- Jun 28, 2026 - Neuroinflammation & Brain Changes (Disease Models & Mechanisms)
- Jun 28, 2026 - Post-Exertional Malaise & Exercise Physiology (Diagnostics, Symptoms & Care Context)
- Jun 28, 2026 - Viral Persistence & Reactivation (Disease Models & Mechanisms)
- Jun 26, 2026 - Gut Microbiome & Dysbiosis (Disease Models & Mechanisms)
- Jun 18, 2026 - Hyperbaric Oxygen Therapy (HBOT) (Treatments & Interventions)
- Jun 18, 2026 - Vagus & Tragus Nerve Stimulation (Treatments & Interventions)
- Jun 16, 2026 - Mitochondrial & Metabolic Dysfunction (Disease Models & Mechanisms)
- Jun 15, 2026 - Immunoadsorption & Apheresis (Treatments & Interventions)
- Jun 11, 2026 - Genetic Risk Factors (Disease Models & Mechanisms)
- Jun 11, 2026 - Vascular Endothelial Dysfunction & Microclots (Disease Models & Mechanisms)
- Jun 2, 2026 - Low-Dose Naltrexone (LDN) (Treatments & Interventions)
- Jun 1, 2026 - Care & Assessment for Severe ME/CFS (Diagnostics, Symptoms & Care Context)
- May 29, 2026 - Autonomic Dysfunction & POTS (Disease Models & Mechanisms)
- May 29, 2026 - Diagnostics & Biomarkers (Diagnostics, Symptoms & Care Context)
- May 10, 2026 - Daratumumab and plasma-cell targeting (Treatments & Interventions)
- May 5, 2026 - Autoimmunity & Autoantibodies (Disease Models & Mechanisms)
- Mar 9, 2026 - Antivirals & Monoclonal Antibodies (Treatments & Interventions)
- Mar 6, 2026 - Small Fiber Neuropathy & Dysautonomia Overlap (Diagnostics, Symptoms & Care Context)
- Dec 25, 2025 - Na-K-ATPase & Muscle Ion Transport (Treatments & Interventions)
- Oct 21, 2025 - Rapamycin & mTOR Inhibition (Treatments & Interventions)
Contact & Feedback
Found a bug, typo, or missing study? Reach out at hannes.ehringfeld@gmail.com.
More Resources
- /r/CFSScience - technical discussion of ME/CFS research.
- CrunchME Visuals - visualizations comparing ME/CFS research metrics.
Important Disclaimer
Not Medical Advice
These pages are research summaries and synthesis notes created by a non-expert with AI assistance. They may contain inaccuracies. Always consult a qualified clinician and read original sources before making health decisions. Use of this content is at your own risk.